Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

HIV Infection

Free Subscription 03.08.2026 11 AIDS 2 Clin Infect Dis 3 HIV Med 3 J Acquir Immune Defic Syndr 3 J Infect Dis 1 J Med Virol 4 J Virol 3 JAMA 1 Lancet Infect Dis 2 N Engl J Med 7 PLoS One 2 PLoS Pathog 1 Science

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AIDS

1. IRWIN S, Elliott J, Li F, Ruiz P, et al
   Altered bile acid metabolism in people with HIV correlates with systemic and intestinal inflammation.
   AIDS. 2026 Jul 23. doi: 10.1097/QAD.0000000000004585.
   PubMed         Abstract available
   
   
2. BHATTACHARJEE M, Phillips N, Schrieff-Brown L, Hoare J, et al
   HIV-associated neurocognitive disorders, among adolescents with HIV in India.
   AIDS. 2026 Jul 23. doi: 10.1097/QAD.0000000000004586.
   PubMed         Abstract available
   
   
3. SUMNER T, Clark RA, Prys-Jones TO, Bakker R, et al
   New tuberculosis vaccines for people with HIV.
   AIDS. 2026 Jul 23. doi: 10.1097/QAD.0000000000004583.
   PubMed         Abstract available
   
   
4. MCGUINTY M, Giguere P, Angel JB
   Cabotegravir/rilpivirine in pregnancy: early insights from clinical practice.
   AIDS. 2026 Jul 24. doi: 10.1097/QAD.0000000000004587.
   PubMed         Abstract available
   
   
5. WILLEMSTEIN IJM, Heijne JCM, Yap K, Illidge J, et al
   Next step after PrEP: HIV prevention pathways among former PrEP users disengaged from care.
   AIDS. 2026 Jul 24. doi: 10.1097/QAD.0000000000004584.
   PubMed         Abstract available
   
   
6. O'BRIEN L, Cross S, Wongkalasin N, Hill A, et al
   Global analysis of pre-exposure prophylaxis to need ratios in 2025.
   AIDS. 2026 Jul 28. doi: 10.1097/QAD.0000000000004589.
   PubMed         Abstract available
   
   
7. CHI BH, Kacanek D, Brown E, Amico KR, et al
   Maternal and pregnancy outcomes in women offered daily oral preexposure prophylaxis during pregnancy and postpartum.
   AIDS. 2026 Jul 28. doi: 10.1097/QAD.0000000000004588.
   PubMed         Abstract available
   
   
8. FALCONER J, Adams J, Molloy S, Mupeli K, et al
   Under pressure: a call to increase access to spinal manometers as a critical component of the management of cryptococcal meningitis.
   AIDS. 2026;40:1219-1224.
   PubMed        
   
   
9. SPIRE B
   Pre-exposure prophylaxis surfing: rethinking partner-dependent HIV prevention strategies among MSM.
   AIDS. 2026;40:1397-1398.
   PubMed        
   
   
10. DAVIES CR, Webber TR, Dirajlal-Fargo S, Funderburg NT, et al
    Early-treated children with perinatal HIV show elevated monocyte activation into late childhood.
    AIDS. 2026;40:1399-1402.
    PubMed         Abstract available
    
    
11. FERRARIS CM, D'Avanzo PA, Knox J, Jennings L, et al
    Parallel declines in antiretroviral therapy adherence by dried blood spot and electronic monitoring in Cape Town, South Africa.
    AIDS. 2026;40:1402-1405.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

12. GRIESEL R, Nunez SA, Cordova E, Perez Rios AM, et al
    Antiviral Effect, Safety, and Tolerability of Oral VH4011499 (VH-499), a New HIV-1 Capsid Inhibitor: Proof-of-Concept Trial.
    Clin Infect Dis. 2026 Jul 29:ciag452. doi: 10.1093.
    PubMed         Abstract available
    
    
13. 
    Correction to: A Phase IV, Open-label, Single-Arm, Multicentric Clinical Trial for Evaluation of Human Papillomavirus 9vHPV Vaccine Immunogenicity in Men Who Have Sex With Men With HIV: GeSIDA Study 10 017.
    Clin Infect Dis. 2026 May 27:ciag318. doi: 10.1093.
    PubMed        
    
    

    
    HIV Med

14. MAYORAL-ALVAREZ J, Fernandez-Ibanez R, Sanchez-Conde M, Hermida JM, et al
    Younger age as a key predictor of follow-up abandonment among PrEP users: A retrospective cohort study in Madrid.
    HIV Med. 2026 Jul 26. doi: 10.1111/hiv.70287.
    PubMed         Abstract available
    
    
15. LAKE JE, Kitch DW, Kantor A, Mayo R, et al
    Semaglutide improves MASLD and MASH in people with HIV: The SLIM LIVER study.
    HIV Med. 2026 Jul 28. doi: 10.1111/hiv.70292.
    PubMed         Abstract available
    
    
16. POLISENO M, Capruzzi D, Cianciaruso A, Colavito N, et al
    UltRaSoUnd-guided evaLuAtion of metabolic health in a cohort of midlife women with HIV: The URSULA study.
    HIV Med. 2026 Jul 28. doi: 10.1111/hiv.70290.
    PubMed         Abstract available
    
    

    
    J Acquir Immune Defic Syndr

17. LEE TY, Onukwugha E, Johnson A, Cassidy-Stewart H, et al
    Harnessing Pharmacy Claims to Strengthen the HIV Care Continuum: Results from the AdhereP4 Program.
    J Acquir Immune Defic Syndr. 2026 Jul 31. doi: 10.1097/QAI.0000000000003945.
    PubMed         Abstract available
    
    
18. OTTO M, Dobra A, Okango E, Tram KH, et al
    Brief report: Aging of the HIV epidemic in a longitudinal population cohort and its implications for the understanding of long-term HIV prevalence trends.
    J Acquir Immune Defic Syndr. 2026 Jul 30. doi: 10.1097/QAI.0000000000003944.
    PubMed         Abstract available
    
    
19. WANG Y, Gornalusse GG, Bhatt U, Siegel DA, et al
    Distinct Transcriptomic Profiles in ART-Treated People with HIV Are Associated with NF-kappaB-regulated Gene Expression and Inflammatory Cytokine Signatures.
    J Acquir Immune Defic Syndr. 2026 Jul 27. doi: 10.1097/QAI.0000000000003929.
    PubMed         Abstract available
    
    

    
    J Infect Dis

20. HUANG X, Wang Z, Wang Y, Song X, et al
    Metabolic Mechanisms of INSTI-Associated Weight Gain: A Multi-Omics Study in Male People with HIV.
    J Infect Dis. 2026 Jul 27:jiag385. doi: 10.1093.
    PubMed         Abstract available
    
    
21. TIMONINA V, Popadin K, Ait Oumelloul M, Calmy A, et al
    Epidemiology and Clinical Impact of Clonal Hematopoiesis in People with HIV.
    J Infect Dis. 2026 Jul 28:jiag393. doi: 10.1093.
    PubMed         Abstract available
    
    
22. ALONSO-RODRIGUEZ N, Edlund IH, Aass HCD, Sopegno C, et al
    CD4+ T cell markers associated with Treatment Outcomes in Tuberculosis: A Sub-analysis of a Phase IIB Trial of Acetylsalicylic acid and Ibuprofen as Adjunctive Therapy.
    J Infect Dis. 2026 Jul 29:jiag380. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Med Virol

23. FRASCA F, Maddaloni L, D'Auria A, Fracella M, et al
    SARS-CoV-2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV.
    J Med Virol. 2026;98:e71067.
    PubMed         Abstract available
    
    

    
    J Virol

24. MAN S, Affandi AJ, Brink HJ, van Hamme JL, et al
    Siglec-1-targeted nanobodies restrict HIV-1 transmission and infection of dendritic cells.
    J Virol. 2026 Jul 29:e0012826. doi: 10.1128/jvi.00128.
    PubMed         Abstract available
    
    
25. PINKEVYCH M, Docken SS, Wu Y, Schlub T, et al
    The rebound-initiating viral reservoir (RIVR) in SIV/SHIV infection is dominated by plasma virus sequences present at the time of ART initiation.
    J Virol. 2026 Jul 28:e0036626. doi: 10.1128/jvi.00366.
    PubMed         Abstract available
    
    
26. DWIVEDI S, Kar S, Horton AP, Gollihar JD, et al
    ViralMap: predicting features in viral proteins from primary sequence.
    J Virol. 2026 Jul 28:e0075726. doi: 10.1128/jvi.00757.
    PubMed         Abstract available
    
    
27. KING HAD, Subra C, Tourtellott E, Swafford I, et al
    Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates.
    J Virol. 2026 Jul 27:e0038926. doi: 10.1128/jvi.00389.
    PubMed         Abstract available
    
    

    
    JAMA

28. ANDERER S
    ACOG Releases New HIV Screening and Prevention Guidelines.
    JAMA. 2026 Jul 31. doi: 10.1001/jama.2026.9494.
    PubMed        
    
    
29. 
    Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: Research Summary.
    JAMA. 2026 Jul 31:e2614955. doi: 10.1001/jama.2026.14955.
    PubMed        
    
    
30. WOODS J, Lebina L, Moller K, Venter WDF, et al
    Initial HIV Therapy for Adults and Treatment-Associated Weight Gain: The Opti-DOR Randomized Clinical Trial.
    JAMA. 2026 Jul 31. doi: 10.1001/jama.2026.14762.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

31. BOYLES T, Ellis J, Feasey N, Heysell SK, et al
    Empiric tuberculosis treatment in hospitalised adults with advanced HIV disease in Africa: applying the therapeutic threshold to clinical practice.
    Lancet Infect Dis. 2026 Jul 27:S1473-3099(26)00351.
    PubMed         Abstract available
    
    

    
    N Engl J Med

32. ROCKSTROH JK, Ramgopal MN, Curran Fabregas A, Hedgcock M, et al
    Phase 3 Trial of Weekly Oral Islatravir-Lenacapavir for HIV-1 Treatment.
    N Engl J Med. 2026 Jul 29. doi: 10.1056/NEJMoa2607973.
    PubMed         Abstract available
    
    
33. KAVANAGH MM, Stiglitz JE, Geingos M, Byanyima W, et al
    The Inequality-Pandemic Cycle - Rethinking Preparedness.
    N Engl J Med. 2026 Jul 29. doi: 10.1056/NEJMp2607839.
    PubMed        
    
    

    
    PLoS One

34. PITUA I, Otto KA, Lwembawo KD, Nantalaga KC, et al
    Urate dysregulation (hyperuricemia and gout) among people living with HIV: A protocol for a systematic review and meta-analysis.
    PLoS One. 2026;21:e0355217.
    PubMed         Abstract available
    
    
35. GLUSKINOS N, Maposhere C, Kufakurinani U, Hove G, et al
    Mixed feelings: Unintended consequences of HIV outreach care in Zimbabwe.
    PLoS One. 2026;21:e0354747.
    PubMed         Abstract available
    
    
36. NGUYEN VM, Hoang T, Tozan Y, Svensson M, et al
    Integrating smoking cessation into HIV care settings: A systematic review and meta-analysis of effectiveness and the evidence gap in cost-effectiveness.
    PLoS One. 2026;21:e0350040.
    PubMed         Abstract available
    
    
37. GBAJA-BIAMILA T, Ezechi O, Adeoti E, Okwuzu J, et al
    A designathon to collaboratively develop sustainable HIV prevention services for youth with community-based organizations in Nigeria.
    PLoS One. 2026;21:e0322076.
    PubMed         Abstract available
    
    
38. LUO Z, Sun W, Pei J, Mutalifu S, et al
    Dynamic transmission and evolutionary analysis of the HIV-1 subtype CRF01_AE pol region in Ningxia, China.
    PLoS One. 2026;21:e0354910.
    PubMed         Abstract available
    
    
39. PYZIAK-KOWALSKA K, Raben D, Sullivan A, Bielecki M, et al
    Indicator condition-guided HIV testing in patients with mononucleosis-like illness and community-acquired pneumonia in an Emergency Department setting: A prospective study from Poland (2015-2018).
    PLoS One. 2026;21:e0354485.
    PubMed         Abstract available
    
    
40. COUTO A, Tiberi O, Templin L, da Cunha M, et al
    How antiretroviral data cleaning reshaped Mozambique's progress to reaching HIV epidemic control.
    PLoS One. 2026;21:e0354368.
    PubMed         Abstract available
    
    

    
    PLoS Pathog

41. DAVE RS, Oludipe AA, Pasipanodya EC, Sherman S, et al
    The brain as an HIV reservoir: Recent findings using autopsy tissues from people with HIV.
    PLoS Pathog. 2026;22:e1014446.
    PubMed         Abstract available
    
    
42. EDWARDS CT, Silva-Trenkle AD, Sahoo A, Cruickshank K, et al
    Non-human primate LIBRA-Seq accelerates neutralizing antibody discovery in RM vaccinated against HIV-1.
    PLoS Pathog. 2026;22:e1013831.
    PubMed         Abstract available
    
    

    
    Science

43. COHEN J
    A rocky rollout.
    Science. 2026;393:450-457.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum